Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-01

Clinical Trial Update: Regulation of Endogenous Glucose Production by Central KATP Channels [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is examining how central KATP channels regulate endogenous glucose production in people with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Meredith Hawkins | Conditions: Type 2 Diabetes Mellitus, Glucose Metabolism Disorders | Phase 2 | Status: RECRUITING